House Committee Calls for CMS Action on Biosimilars Tony Hagen | The Center for Biosimilars “Alex Brill, founder of economic consulting firm Matrix Global Advisors and a resident fellow at the American Enterprise Institute, discussed a solution that Congress or...
Observable Flaws in CMS’s Dialysis Star-Rating System and a Proposed Alternative Alex Brill | Bloomberg BNA In January 2015, CMS launched a star-rating system for U.S. dialysis facilities. This article analyzes nearly 6,000 U.S. dialysis facilities and explores...
